XBiotech saw the highest growth of 99% in patent filings in November and 99% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 32% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of XBiotech’s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

XBiotech has been focused on protecting inventions in United States(US) with three publications in Q4 2023

The United States(US) Patent Office dominates the patent filings and grants with nearly 100% filings and 100% grants. The United States(US) patent Office are among the top ten patent offices where XBiotech is filings its patents. Among the top granted patent authorities, XBiotech has 100% of its grants in United States(US)

Amgen and Johnson & Johnson could be the strongest competitors for XBiotech

Patents related to rare diseases lead XBiotech's portfolio

XBiotech has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q4 2023.

Fatigue related patents lead XBiotech portfolio followed by ascites, and giant lymph node hyperplasia (castleman's disease)

XBiotech has highest number of patents in fatigue followed by ascites, giant lymph node hyperplasia (castleman's disease), bacteremia, and staphylococcus aureus infections.

For comprehensive analysis of XBiotech's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.